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Edited by Gianni CesareniAbstract ICP34.5, encoded by herpes simplex virus 1, is a pro-
tein phosphatase 1 (PP1) regulatory subunit that mediates
dephosphorylation of the a subunit of translation initiation factor
2 (eIF2a). However, the mechanism of its action remains poorly
understood. Here, we show that amino acid substitutions in the
arginine-rich motif have diﬀerential eﬀects on ICP34.5 activity.
The phenotypes parallel with viral protein synthesis and cyto-
pathic eﬀects in virus infected cells. Besides the consensus PP1
binding motif, the Arg-motif appears to enhance the interaction
between ICP34.5 and PP1. These results suggest that concerted
action between the PP1 binding domain and the eﬀector domain
of ICP34.5 is crucial for eIF2a dephosphorylation and viral pro-
tein synthesis.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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ICP34.5, a protein encoded by c134.5 gene of herpes simplex
viruses (HSV), is essential for replication in vivo [1–3]. ICP34.5
antagonizes the host response mediated by the double-
stranded RNA dependent protein kinase (PKR ) in the early
stage of in infection and facilitates viral egress in the late stage
of infection [8]. In infected cells, HSV DNA replication acti-
vates PKR, which phosphorylates the a subunit of translation
initiation factor 2 (eIF2a) and shuts oﬀ viral protein synthesis
[4]. As a countermeasure, ICP34.5 is expressed to recruit cellu-
lar protein phosphatase 1 (PP1) that dephosphorylates eIF2a
[5,6]. As a result, the eﬃcient viral replication and productive
viral infection proceed.
ICP34.5 consists of an amino-terminal domain, a linker
region of triplet repeats (Ala-Thr-Pro), and a carboxyl-termi-*Corresponding authors. Address: College of Life Sciences, Nankai
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doi:10.1016/j.febslet.2007.11.082nal domain [6,7]. The amino terminal domain is implicated
in virus maturation, by a yet unclear mechanism [8]. The linker
region, with a varying number of the triplet repeats, modulates
neuroinvasion [9]. The carboxyl terminal domain functions to
counteract the PKR response by host cells [6,10]. This portion
of the viral protein is homologous to the corresponding
domain of the cellular protein GADD34 expressed under stress
conditions, such as DNA damage, apoptosis and ER stress,
and involved in the negative regulation of a stress-inducible
gene CHOP [11–14]. The carboxyl terminus of ICP34.5, func-
tionally interchangeable with that of GADD34, binds and
redirects PP1 to eIF2a [6,15]. Site-speciﬁc mutations in the
PP1 binding domain, with a signature motif present in other
PP1 interacting proteins, abolish eIF2a dephosphorylation
and impairs viral replication [5,16,17]. In addition, mutations
in the putative eﬀector domain disrupt the activity of
ICP34.5 [16,18,19]. However, the role of the eﬀector domain
in this process remains unknown.
In this work, we have characterized an Arg rich region with
a stretch of conserved amino acids distal to the PP1 binding
domain. We report that Arg residues in this region have diﬀer-
ential eﬀects on eIF2a dephosphorylation by PP1 both in vitro
and in vivo. We also demonstrate that viral protein synthesis
and cytopathic eﬀects parallel with the extent of eIF2a dephos-
phorylation in virus infected cells. Our data leads to the point
that the cooperation of PP1 binding domain and eﬀector do-
main is of critical importance to the biochemical and biological
functions of ICP34.5 to promote viral protein synthesis and
eﬀective infection.2. Materials and methods
2.1. Cells and virus
Vero, Hela, HEK293T and NIH3T3 cell lines were obtained from
the American Type Culture Collection and propagated in Dulbeccos
modiﬁed Eagles medium supplemented with 10% fetal bovine serum
(Hela and HEK293T) or 10% new born calf serum (Vero and
NIH3T3). Recombinant virus R3616 lacks a 1 kb fragment encom-
passing the c134.5 gene [1].
2.2. Plasmids
Plasmid encoding human PP1c, pCMVneoPP1CS1a, was a gift from
Dr. Anna DePaoli-Roach (Indiana University School of Medicine, IN).
The ICP34.5 mutants were derived from pRB143 which contains the
BamHI S fragment of HSV-1(F) DNA. For bimolecular ﬂuorescenceblished by Elsevier B.V. All rights reserved.
Fig. 2. Dephosphorylation of eIF2a in vitro. Puriﬁed eIF2a was
phosphorylated at 34 C by PKR for 30 min. An aliquot was added to
reaction solutions containing the lysates of cells transfected plasmids
encoding none (Ctrl), ICP34.5 (WT), or ICP34.5 mutants, respectively.
Samples were incubated for 10 min at 34 C, then subjected to SDS–
PAGE, and Western blot analysis with antibodies against the
phosphorylated eIF2a at Ser-51 (the top panel), eIF2a (the middle
panel), and ICP34.5 (the bottom panel), respectively.
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WT, 3A, R255D, EDD, ED, and V193E, F195L were fused to the nucle-
otide encoding the carboxyl-terminal fragment containing residues
155–238 (YC) of YFP, respectively. The PP1 coding region was fused
to sequences encoding residues 1–154 (YN) of YFP. The fused regions
were connected by linker sequences as recommended [20].
2.3. Immunoblot analysis
Cells were harvested and lysed in buﬀer containing 50 mM Tris–HCl
(pH 8.0),150 mM NaCl, 0.5% deoxycholic acid, 0.1% SDS, 1% NP
40%, and protease inhibitor cocktail at 4 C. After centrifugation,
supernatants were subjected to SDS–PAGE and Western blot with
antibodies against ICP34.5, HSV antigens (Dako Corporation), phos-
phorylated eIF2a-Ser-51 (Biosource Inc.), eIF2a (Cell Signaling Tech-
nology Inc.), or a-tubulin antibody (Sigma), as indicated respectively.
2.4. In vitro eIF2a dephosphorylation assay
GST-PKR fusion protein was expressed and puriﬁed from Esche-
richia coli BL21(DE3) strain as described previously [18]. Cytoplasmic
S10 fractions were prepared from lysates of Hela cells transfected by
the plasmids encoding wild-type ICP34.5 and the mutants as described
previously [6]. To prepare phosphorylated eIF2a as substrate, eIF2
puriﬁed from rabbit reticulocytes was incubated with GST-PKR and
0.1 mM ATP in the reaction buﬀer containing 20 mM Tris–HCl (pH
7.5), 40 mM KCl, and 2 mM MgCl2 for 30 min at 34 C. Aliquots of
the phosphorylated eIF2a were then reacted with S10 fractions in buf-
fer containing 20 mM Tris–HCl (pH 7.5), 40 mM KCl, 2 mM MgCl2,
and 0.1 mM EDTA at 34 C for 10 min. The reaction was stopped and
samples were subjected to Western blot analysis with antibodies
against eIF2a and eIF2a Ser-(P)-51, respectively.
2.5. Bimolecular ﬂuorescence complementation (BiFC) assays
The BiFC method was adopted to investigate protein–protein bind-
ing in HeLa cells [20]. Brieﬂy, constructs encoding fusion proteins, YC-
34.5 variants and YN-PP1, were co-transfected into Hela cells grown
on glass cover slips using Lipofectamine2000 (Invitrogen). At 48 h
post-transfection, cell culture dishes were placed at room temperature
for 1–3 h and stained with DAPI prior to microscopic analysis. The
ﬂuorescence emission was examined in living cells by confocal micros-
copy and images were processed using Olympus Fluoview FV1000.
YFP ﬂuorescence of living cells was also subjected to FACS analysis
with excitation wavelength at 500 nm and emission wavelength at
535 nm.Fig. 1. (A) Amino acid sequence alignment of the carboxyl terminal dom
GADD34 proteins of Hamster (AAA36983), human (AAC25631.1), and mou
motifs are underlined. (B) Site-speciﬁc mutants constructed in this work. Nu2.6. Virus infection assays
Recombinant retroviruses were generated as described previously
[21]. Brieﬂy HEK293T cells were transfected with plasmid pHIV-
34.5WT, pHIV-3A, pHIV-R255D, pHIV-EDD, pHIV-V193E, F195L,
or HIV-GFP, along with pHIV-trans and pVSVG using calcium
phosphate precipitation method. At 48-hour post-transfection, culture
media containing the recombinant viral particles were collected to
transduce NIH3T3 cells. Monolayers of transduced cells were either
mock-infected or infected with c134.5 null virus R3616. At an indicated
time point after infection, cells were examined with a microscope or
harvested to determine viral protein production by Western blot anal-
ysis [16].3. Results
3.1. Eﬀects of amino acid substitutions in ICP34.5 on eIF2a
dephosphorylation
Sequence alignment was carried out with the carboxyl termi-
nal domains derived from ICP34.5 of HSV type I and type II,
and GADD34 of human, mouse, and hamster speciesains of ICP34.5 from HSV-1 (AAA45790.1), HSV-2 (NP_044529),
se (NP_032680). The PP1 conserved sequences of binding and Arg rich
mbers denote amino acid positions.
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among these proteins. The region bearing the signature
sequence (KVxF) represents the PP1 binding motif, and the
region carboxyl terminal to this domain is tentatively deﬁned
as the eﬀector domain. We focused on a conserved segment
with a cluster of Arg and Ala, which spans amino acid 248–
256. Site-speciﬁc mutations were designed based on size, polar-
ity, and electric charge (Fig. 1B). Substitutions of amino acid
were also introduced to the PP1 binding motif as a control.
Cells were transiently transfected with plasmids expressing
ICP34.5 variants and the lysates were processed for protein
expression by Western blot analysis with anti-ICP34.5 anti-
body. Aliquots of lysate were subjected to in vitro dephospho-Fig. 3. Interaction between PP1 and ICP34.5 variants. (A) Co-immunoprecip
with plasmid encoding HA-tagged ICP34.5 variants or plasmid backbone a
antibody and protein G-agarose. The co-precipitated proteins were resolved
(upper two panels). Aliquots of lysates were also used to verify the express
Visualization of ICP34.5 and PP1 interactions in live cells. Hela cells were co-
PP1 and YC-ICP34.5 variants, respectively. At 48 h after transfection, ce
microscopy (left) and FACS analysis (middle). The mean values of YFP in
variants.rylation assay as described in Section 2. As expected, wild-type
ICP34.5 (WT) mediated eIF2a dephosphorylation eﬃciently
whereas the PP1 binding mutant (V193E, F195L) failed to do
so (Fig. 2, lanes 2 and 3). As expected, the control lysate (Ctrl)
did not facilitate eIF2a dephosphorylation (Fig. 2, lane 1). It
appears that a basic residue or non-polar residue is tolerated
at position 255, whereas, acidic residue substitution in Arg
255 by Asp marginally reduced eIF2a dephosphorylation
(Fig. 2, lanes 5–7), suggesting that a negatively charged residue
is only partially disruptive at this position. Substitutions in
Arg-249 and Arg-251 with Glu and Asp, respectively (ED)
completely impaired eIF2a dephosphorylation (Fig. 2, lane 9)
to the same extent as an additional substitution of Arg-255itation of ICP34.5 mutants with PP1. HEK293T cells were transfected
s control(Ctrl), respectively. Cell lysates were incubated with anti-HA
by Western blot analysis using antibodies against PP1 and ICP34.5
ion of ICP34.5 variants and endogenous PP1 (lower two panels). (B)
transfected with plasmids encoding YFP fragments fused proteins, YN-
lls were stained with DAPI and subjected to confocal ﬂuorescence
tensity (right) represent the relative binding eﬃciency of PP1-ICP34.5
174 C. Zhang et al. / FEBS Letters 582 (2008) 171–176with Asp (EDD) (Fig. 2, lane 8). Similarly, a triple substitution
at Arg-249, Arg-251 and Arg-255 with Ala drastically reduced
eIF2a dephosphorylation. These results suggest that Arg-249
and Arg-251 play indispensable role in ICP34.5 mediated
PP1 activity towards eIF2a.
3.2. Interaction between protein phosphatase 1 and ICP34.5
variants
Since mutations in the Arg rich motif negatively aﬀect eIF2a
dephosphorylation, we examined whether this region contrib-
utes to PP1 binding. At ﬁrst, we addressed this issue by co-
immunoprecipitation. Speciﬁcally, cells were transfected with
one of the plasmids encoding ICP34.5 variants. Lysates of cells
were then analyzed for protein expression. As shown in
Fig. 3A (upper panels), the co-immunoprecipitation experi-
ment validated the binding of PP1 with ICP34.5 (WT), but
not the PP1 binding mutant (V193E, F195L). It also revealed
that, under this experimental condition, those mutations at
Arg rich motif were capable of binding PP1 eﬃciently. The
expression of ICP34.5 variants was veriﬁed to be comparable
in Fig. 3A (lower panels).
We further investigated the interaction between PP1 and
ICP34.5 in live cells by recently developed and widely accepted
bimolecular ﬂuorescence complementation (BiFC) assay. This
method allows live detection of the biological interaction of
two binding partners [20]. As described in Section 2, a pair
of constructs encoding fusion proteins YN-PP1 and YC-34.5
or mutants was co-transfected into Hela cells and examined
by confocal ﬂuorescence microscopy. As shown in Fig. 3B
(images), wild-type ICP34.5 (WT) associated with PP1 as illus-
trated by a strong ﬂuorescent signal. In contrast, the PP1 bind-
ing mutant (V193E, F195L) was unable to interact with PP1
(Fig. 3B, the second row). Interestingly, mutants with amino
acid substitutions in the Arg rich motif (3A, R255D, EDD,
and ED) still associated with PP1 in the cytoplasm, suggesting
that these mutants are capable of forming the ICP34.5-PP1
complexes. It is worth noting that despite the fact that
ICP34.5 exists in both the nucleoli and cytoplasm [20], the
interaction between PP1 and ICP34.5 was only seen in the
cytoplasm.Fig. 4. Viral protein synthesis and endogenous eIF2a dephosphorylation. (
indicated ICP34.5 variants, respectively. On day 5, cells were infected with the
and lysates prepared for Western blot analysis with antibody against HSV
densitometry and presented as a ratio relative to a-tubulin. (B) Endogenous
antibodies against eIF2a and phosphorylated eIF2a, respectively. (C) Expr
ICP34.5 antibody.To compare the binding eﬀect of ICP34.5 variants with PP1,
cells were subjected to ﬂow cytometry analysis (Fig. 3B, histo-
grams). The mean ﬂuorescence intensity was measured
(Fig. 3B, right column) as this parameter reﬂects the relative
binding eﬀect based on a long half-life of the associated frag-
ments [20]. By comparison with the arbitrary baseline deﬁned
by the maximal ﬂuorescence intensity of PP1 binding mutant
(V193E, F195L) (Fig. 3B, the dotted vertical line across the his-
tograms), it is evident that wild-type ICP34.5 eﬃciently formed
a complex with PP1, with a score of 293.21. Likewise, ICP34.5
mutants with amino acid substitutions exhibited positive in
complex formation. In this respect, R255D and 3A substitu-
tions had modest eﬀects, with binding scores of 220.9 and
257.8, respectively. In contrast, EDD and ED substitution re-
sulted in a signiﬁcant decrease, with binding scores of 165.8
and 158.06, respectively. Expression of each binding partners
were examined to be equivalent (data not shown). Collectively,
these results suggest that the Arg rich motif contributes to the
eﬃciency of the ICP34.5-PP1 association.
3.3. The role of the Arg rich motif in viral protein synthesis
In infected cells, wild-type HSV, but not the c134.5 null
mutant R3616, prevents the shut-oﬀ of protein synthesis [4].
To further evaluate the eﬀect of the Arg rich motif in a phys-
iologically relevant system, we measured viral polypeptide
synthesis compensated by the ICP34.5 variants. Speciﬁcally,
NIH3T3 cells were transduced with recombinant retrovirus
particles expressing ICP34.5 variants, and then challenged
with R3616. The cell lysates were processed for Western blot
analysis using antibodies speciﬁc to HSV proteins. As shown
in Fig. 4A, viral protein synthesis in cells expressing wild-type
ICP34.5 was of fourfold as that in cells expressing GFP or
the PP1 binding mutant (V193E, F195L). Although R255D
substitution had no eﬀect, other mutations (3A, EDD, and
ED) led to a 2–3-folds reduction in viral protein synthesis
in comparison with wild-type ICP34.5 (Fig. 4A). In parallel,
dephosphorylation of endogenous eIF2a correlated well with
the viral protein synthesis proﬁles (Fig. 4B). Expression of
ICP34.5 in retrovirus transduced cells was conﬁrmed in
Fig. 4C.A) NIH3T3 cells were transduced by retrovirus expressing GFP and
c134.5 null virus R3616 at 10 pfu per cell for 12 h. Cells were harvested
-1 proteins and a-tubulin. Viral protein synthesis was quantitated by
eIF2a and phosphorylated eIF2a were detected by Western blot with
ession of ICP34.5 variants in transduced cells was veriﬁed with anti-
Fig. 5. Virus induced cytopathic eﬀects. Monolayers of transduced NIH 3T3 cells were infected with the c134.5 nullmutant R3616 at 0.05 pfu per cell.
At 48 h post-infection, cells were examined with a light microscope and images were captured.
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eﬀects
HSV infection typically induces morphological changes and
consequently destroys infected cells due to active viral replica-
tion. To assess the biological signiﬁcance of eIF2a dephospho-
rylation mediated by ICP34.5 variants, we also examined the
cytopathic eﬀects in virus-infected cells. As described above,
NIH3T3 cells were transduced with various constructs and
then mock infected or infected with the c134.5 null virus
R3616. At 48 h post-infection, the cells were examined by light
microscopy. As illustrated in Fig. 5, mock-infected cells
formed a monolayer, with most cells displaying spindle mor-
phology (Fig. 5a). In cells expressing GFP or the PP1 binding
mutant (V193E, F195L), the c134.5 null virus did not cause any
major changes as compared to mock-infected cells (Fig. 5, pan-
els a, c and d). In contrast, cells expressing wild-type ICP34.5
or R255D exhibited dramatic changes as many cells became
rounded up and formed clumps (Fig. 5, panels c and f). Nota-
bly, a large portion of cells were destroyed by virus infection
where no intact cells were seen, indicating an eﬃcient viral
infection. In cells expressing 3A, EDD, or ED, the virus in-
duced merely moderate cytopathic eﬀects. Some cells exhibited
cell rounding and clumping, indicative of a partial viral repli-
cation. Therefore, these cytopathic eﬀects correlated well with
the ability of ICP34.5 to mediate PP1 binding, eIF2a dephos-
phorylation, and viral protein synthesis.4. Discussion
In mammalian cells, activated PKR induced by interferon
phosphorylates eIF2a, leading to the shut-oﬀ of protein
synthesis and thus the inhibition of viral replication. In this
respect, many viruses, including herpes viruses, have evolved
mechanisms to escape the antiviral response [22]. Previous
studies demonstrate that evasion of the PKR response is essen-
tial for HSV infection, which involves the c134.5 gene product
[4,6,18]. This process requires the carboxyl terminus of the
ICP34.5 protein that bears a PP1 binding motif and a putative
eﬀector domain [5,10,16].Our analysis indicates that amino acid substitutions in the
Arg rich motif of ICP34.5 aﬀect eIF2a dephosphorylation.
Furthermore, site-speciﬁc mutations in the Arg rich region of
ICP34.5 appeared intact to PP1 binding in co-immunoprecip-
itation analysis, is consistent with that reported for GADD34
mutants [23]. However, the diﬀerential eﬀect on PP1 binding
was evident in live cells. These data raise the hypothetical mod-
el in which, while ICP34.5 determines the PP1 binding by the
hydrophobic groove as that seen in other PP1 regulatory sub-
unit, such as GM [17], the Arg rich motif plays an accessory
role in ﬁne-tuning PP1 binding. Crystal structure of ICP34.5
is not yet available, but secondary structure prediction suggests
that there are three a-helixes in the eﬀector domain. Additional
work is required to evaluate the impact of mutations on the
structure of ICP34.5.
In HSV infected cells, ICP34.5 mediated eIF2a dephospho-
rylation renders viral polypeptide synthesis [6,16]. In this re-
gard, the Arg rich motif is a functional element in the
context of HSV infection. First, deﬁcient protein synthesis in
cells infected with c134.5-null virus R3616 was rescued by
expression of wild-type ICP34.5 or R255D, but not mutations
in multiple Arg residues. Second, the above phenotypes corre-
late well with eIF2a dephosphorylation. Third, viral protein
synthesis was mirrored by the extent of cytopathic eﬀects seen
in infected cells.
In summary, we demonstrated the correlation of biochemi-
cal and biological roles of the conserved Arg motif of
ICP34.5 in HSV infection. We also addressed the diﬀerential
eﬀect of Arg mutants on PP1 binding, leading to the hypothe-
sis that the cooperation of PP1 binding domain and eﬀector
domain is of critical importance to the function of ICP34.5.
Further studies on three-dimensional structure would help to
understand the mechanism.
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